Evidence map›Paper›PMID 39576575›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Importance of Secondary Structure Data in Large Scale Protein Modeling Using Low-Resolution SURPASS Method.

Aleksandra E Badaczewska-Dawid, Andrzej Kolinski

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aleksandra E Badaczewska-DawidOffice of Biotechnology, Iowa State University, Ames, IA, USA. abadacz@iastate.edu.ORCID 0000-0003-1832-4364
Andrzej KolinskiFaculty of Chemistry, University of Warsaw, Warsaw, Poland. kolinski@chem.uw.edu.pl.ORCID 0000-0002-8830-2315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary structure elements, such as alpha helices and beta strands, play a fundamental role in defining the overall fold of a protein. Leveraging secondary structure information is essential for encoding the structural features in coarse-grained protein models. Such models simplify the representation of amino acid residues, thereby reducing computational complexity. By incorporating accurate (even if only partial) secondary structure data, the models can efficiently search for the native conformation of proteins and preserve the core structural motifs across extended time frames. Here, the pivotal role of (predicted) secondary structure data in the coarse-grained modeling of protein tertiary and quaternary structures, along with their long-time dynamics, is investigated. Computational simulations of large protein systems using a low-resolution SURPASS model were performed. These case studies demonstrate the sufficiency of predicted secondary structure data in an accurate fold assembly. It leads to a realistic depiction of long-time dynamics in the recorded pseudo-trajectories by employing the Monte Carlo dynamics sampling schema, based on a long random sequence of local conformational modifications. This approach may provide a powerful tool for investigating the critical stages of protein folding. Future combination with knowledge-based potentials derived using machine learning techniques offers exciting opportunities to unravel the underlying mechanisms of biological processes in a variety of molecular complexes.

Indexed as

ProteinsProtein Structure, SecondaryAlgorithmsComputational BiologyModels, MolecularMolecular Dynamics SimulationMonte Carlo MethodProtein ConformationProtein FoldingProteinsCoarse-grainedKnowledge-basedMultiscale modelingProtein dynamicsSURPASS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.